University of Virginia Research Highlights Regional Talent Needs Amid Rapid Bioscience Growth
The Office of the Vice President for Research at the University of Virginia is underscoring the critical importance of coordinated bioscience talent development in Central Virginia following the release of Talent Pathways: A Biosciences Workforce and Talent Strategy for GO Virginia Region 9, a new regional workforce analysis led by CvilleBioHub in partnership with TEConomy Partners.
The report’s findings come at a pivotal moment of unprecedented growth driven by major research, innovation, and advanced manufacturing investments across the region. Central Virginia’s biosciences industry has grown 23% between 2019 and 2024, now supporting 2,100 jobs across 254 establishments, with industrial biosciences roles averaging $121,000 annually�”placing the sector among the strongest economic engines in the Commonwealth. Yet the report identifies a widening gap between employer demand and available talent, with fewer than one-third of bachelor’s level life sciences graduates remaining in the region long-term.
UVA’s Expanding Role in Central Virginia’s Bioscience Workforce Ecosystem
The report further highlights that the region’s talent demand is accelerating in direct connection with major forthcoming investments, including the UVA Manning Institute of Biotechnology, which will significantly expand research and commercialization capacity in areas such as therapeutics, biomanufacturing, and translational science.
According to the Talent Pathways report, the region faces acute needs in:
- Medical scientists
- Lab and biological technicians
- Skilled biomanufacturing production workers
- QA/QC specialists
- Biomedical engineers
- Data science and software developers
As a leading research institution and a core partner in regional economic development, UVA is deeply engaged in strengthening the bioscience talent pipeline. UVA is already partnering with CvilleBioHub to launch the region’s first wetlab accelerator�”the Commonwealth BioAccelerator, housed at North Fork, a UVA Discovery Park�”designed to prepare emerging companies for commercialization of new medical, therapeutic, and life sciences innovations.
UVA continues to expand its leadership in biotechnology education through a growing portfolio of interdisciplinary programs that bridge science, medicine, engineering, and business. At the McIntire School of Commerce, the M.S. in Commerce Biotechnology Track prepares life-science graduates to translate scientific discoveries into real-world impact by combining biotechnology science, commercialization strategy, and industry engagement. Complementing this program are plans for more graduate training pathways across Grounds, including biotechnology-focused master’s programs in Chemical Engineering and emerging graduate-level coursework in drug development and translational science. Together, these initiatives reflect UVA’s commitment to preparing the next generation of leaders who can advance new therapies, build life-science companies, and accelerate the commercialization of biomedical innovation.
The analysis, based on extensive interviews with industry, UVA leadership, and education partners, points to an urgent need for aligned talent development strategies across K�”12, community colleges, universities, and industry.
UVA sees the Talent Pathways report as a call to action for coordinated, regionwide leadership. By aligning research excellence, workforce development, and industry partnerships, the University is dedicated to helping Central Virginia build one of the nation’s most dynamic bioscience talent engines. This collaborative momentum positions the region not only to meet accelerating industry demand, but to lead the future of biotechnology innovation.
To receive a copy of the report, request access via this form.
Media contact:
Catherine West
Hyk5sz@virginia.edu